Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 297

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 16C
Chunk 297
---
 pre-approve services to the chairperson of the Audit Committee. The decisions of the chairperson to grant pre-approvals must be presented to the full Audit Committee at its next scheduled meeting. The Audit Committee may not delegate its responsibilities to pre-approve services to the management.

The Audit Committee has considered the non-audit services provided by Deloitte & Associés and PricewaterhouseCoopers Audit as described above and believes that they are compatible with maintaining Deloitte & Associés’s and PricewaterhouseCoopers Audit's independence as the independent registered public accounting firms.

Item 16D. Exemptions from the Listing Standards for Audit Committees.